Pregnant women who contract Covid-19 in their third trimester are unlikely to pass it on to their unborn babies, research shows.
- Researchers studied and followed 64 pregnant women who had Covid
- None of their babies have been infected with the coronavirus after birth
- Also no coronavirus was found in the placenta of the baby
Pregnant women who contract the coronavirus don’t pass it on to their unborn children, data from a new study shows.
US researchers followed 64 women who tested positive for SARS-CoV-2, the virus that causes COVID-19, between April 2 and June 13.
None of the babies tested positive for Covid-19 after they were born, and no coronavirus was detected in the placenta.
Although Harvard academics warn that the small sample size makes it impossible to rule out some pregnant women passing the virus on to their children, it shows that pregnancy’s natural defenses ward off the virus, they say.
Scroll down for video

US researchers followed 64 women who tested positive for SARS-CoV-2, the virus that causes COVID-19, between April 2 and June 13. None of the babies tested positive for Covid-19 (stock)
The expectant mothers were all in their third trimester and had the virus in their lungs, nose, and throat, but not in their bloodstream or placenta.
Other data, including information on women who contracted the virus earlier in their pregnancy, will be published soon, the researchers say.
The latest study was conducted at Massachusetts General Hospital and Harvard Medical School, and funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in Washington DC.


The expectant mothers were all in their third trimester and had the virus in their lungs, nose and throat, but not in their bloodstream or placenta. Other data, including information on women who contracted the virus earlier in their pregnancy, will be published soon (stock)
Dr. Diana Bianchi, director of the NICHD, said: ‘This study provides some assurance that SARS-CoV-2 infections are unlikely to pass through the placenta to the fetus during the third trimester, but more research needs to be done to confirm this finding . . ‘
Of those who tested positive for SARS-CoV-2 in the study, 23 were asymptomatic, 22 had mild illness, seven had moderate illness, ten had severe illness, and three had critical illness.
In addition to those who tested positive, an additional 63 pregnant women who were COVID negative and 11 women who were not pregnant were included in the study for comparison.
The researchers found that the risk of decreased blood flow in the placenta was higher in women who suffered the worst cases of the disease.
They also saw lower than expected levels of protective antibodies in the umbilical cord blood, but much higher levels of influenza-specific antibodies.
This, they say, may be due to the flu shot and suggests that COVID antibodies are not passing through the placenta, as well as antibodies that target other viruses.
The results also showed that only very low levels of COVID antibodies reached the unborn child, raising more questions about possible immunity.
The author of the study, Dr. Andrea Edlow, of Massachusetts General Hospital and Harvard Medical School, said, “ It will be important to determine why these maternal antibodies are less likely to cross the placenta and whether these decreased antibody transmission to newborns. more vulnerable to SARS. CoV-2 infection, compared to other infections.
It will be important to determine how lower levels of maternal SARS-CoV-2 antibodies may affect preterm infants’ health outcomes, as COVID-19 may increase the risk of preterm birth.
The findings are published in the journal JAMA Network Open.